Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)

[1]  Chiun Hsu,et al.  14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma , 2013, PloS one.

[2]  A. Cucchetti,et al.  Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients. , 2012, World journal of gastroenterology.

[3]  Jiamei Yang,et al.  Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma , 2012, Annals of Surgical Oncology.

[4]  B. Jia,et al.  Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma , 2012, Molecular and Cellular Biochemistry.

[5]  M. Koch,et al.  Hepatocellular Carcinoma: Current Management and Perspectives for the Future , 2011, Annals of surgery.

[6]  P. Wei,et al.  Knockdown of Thrombomodulin Enhances HCC Cell Migration through Increase of ZEB1 and Decrease of E-cadherin Gene Expression , 2010, Annals of Surgical Oncology.

[7]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[8]  Michael K. Wendt,et al.  Mechanisms of the epithelial-mesenchymal transition by TGF-beta. , 2009, Future oncology.

[9]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[10]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[11]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[12]  S. Natsugoe,et al.  Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. , 2008, Journal of hepato-biliary-pancreatic surgery.

[13]  K. Behrns,et al.  Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways , 2008, Hepatology.

[14]  Meenakshi Singh,et al.  ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease , 2008, Modern Pathology.

[15]  B. Zhou,et al.  New insights of epithelial-mesenchymal transition in cancer metastasis. , 2008, Acta biochimica et biophysica Sinica.

[16]  W. Lau,et al.  Hepatocellular carcinoma: current management and recent advances. , 2008, Hepatobiliary & pancreatic diseases international : HBPD INT.

[17]  A. Osunkoya,et al.  Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. , 2008, Cancer research.

[18]  S. Baylin,et al.  Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer , 2008, Clinical Cancer Research.

[19]  Connie Wang,et al.  Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro* , 2007, Journal of Biological Chemistry.

[20]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[21]  G. Berx,et al.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.

[22]  K. Horwitz,et al.  The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. , 2006, Cancer research.

[23]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[24]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[25]  M. Buendia,et al.  Altered expression of E‐cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β‐catenin expression, and clinical features , 2002, Hepatology.

[26]  Y. Joo,et al.  Expression of E-Cadherin, Alpha- and Beta-Catenins in Patients with Pancreatic Adenocarcinoma , 2002, Pancreatology.

[27]  L. Nelles,et al.  SIP1, a Novel Zinc Finger/Homeodomain Repressor, Interacts with Smad Proteins and Binds to 5′-CACCT Sequences in Candidate Target Genes* , 1999, The Journal of Biological Chemistry.

[28]  K. Syrigos,et al.  Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. , 1998, Anticancer research.

[29]  H. Koizumi,et al.  Expression of epithelial cadherin and α‐ and β‐catenins in nontumoral livers and hepatocellular carcinomas , 1996 .

[30]  H. Kondoh,et al.  Delta-crystallin enhancer binding protein delta EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. , 1993, Development.

[31]  PhD Shinichi Ueno MD,et al.  Strong Smad4 Expression Correlates with Poor Prognosis After Surgery in Patients with Hepatocellular Carcinoma , 2009, Annals of Surgical Oncology.

[32]  H. Koizumi,et al.  Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. , 1996, Hepatology.